chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hairloss; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (hairloss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced ALOPECIA (hairloss). At the time of the report, ALOPECIA (hairloss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided. Treatment products were not provided.
Constant Nausea and repeated vomiting from approximately 3am to approximately 9am.  No clue why, I didn't eat or drink anything unusual.  No alcohol or drugs and I'm not pregnant.
About 7 hours post injection, I started experiencing general increasing discomfort and almost unbearable heat at the injection site.  In addition, I started feeling light-headed and had loud ringing in my ears.  I was able to move to a chair and sit down, and a family member provided me with a cold pack to place on my arm.  Eventually, the ringing in my ears subsided and I no longer felt like I was going to pass out.  This episode lasted for about 20 - 30 minutes.  I was chilled for the remainder of the evening on 4/17.2021.  Today (4/18/2021), I have had periods of light-headedness, but not nearly as severe as yesterday.
Starting around 2 weeks after second vaccine began having itchy hives on face. Happens randomly several times a day in the 2nd and 3rd week after vaccine.  Have photos as documentation. No significant changes in any other medication, diet or environmental factors- or skin care. Can only attribute as a delayed immune response to the vaccine?
This spontaneous report as received from a Medical Assistant refers to a 10 and half months old infant patient of unknown gender. Pertinent medical history, drug reactions and allergies was not reported. On an unknown date the patient was vaccinated with VAQTA, a 0.5 mL dose. (Lot# and expiration date was not provided). Additional information has been requested.
Severe headache, dizziness, weakness, sharp pain in forearms, neck and shoulders.  All started the day after the shot and continues to be an issue today (2 days later).
Missed 2 days of work due to flu-like symptoms with fever, body aches, headache and nausea, on day 8 and 9 of vaccination. Symptoms resolved on day 10.
This spontaneous report as received from a registered nurse refers to a 68 year old female patient with scoliosis and allergy to sulfa antibiotics. The patient's medical history included chest pain, diverticulitis, shingles and headaches. On 14-SEP-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 which had a lot number of M027552, intramuscular (expiration date was not reported). The patient was not taking any concomitant medications. On 14-SEP-2016, at the evening, the patient developed bruising at the site of vaccination, her lower arm 3-4 inches and her above arm was swollen, hot to touch and red. The patient received an unspecified treatment for the adverse events. There was no product quality issue involved. At the reporting time, the patient was recovering from the events. The reporter did not assess the relationship between the events and PNEUMOVAX 23. Additional information has been requested.
Tested positive for Covid-19 on 8/24/2021, SOB and low grade fever
flu; fever; chills; body ache; fatigue; This is a spontaneous report from a contactable healthcare professional. A 66-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3248) on her left arm, via an unspecified route of administration on 15Jan2021 15:00 at a single dose for COVID-19 immunization. Medical history included Allergies, Asthma, Sleep Apnea, Obesity, IBS, Depression and Arthritis. Concomitant medication included paroxetine hydrochloride (PAXIL), buspirone, unspecified allergy shots. The patient experienced Flu, Fever, Chills, Body Aches, Fatigue; all on 16Jan2021 09:45. No treatment was received for the events. The outcome of the events was recovered on an unspecified date in Jan2021.
This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a elderly female patient who received SHINGRIX for prophylaxis. On 11th September 2018, the patient received the 1st dose of SHINGRIX. In September 2018, 14 days after receiving SHINGRIX, the patient experienced ringing in ears. On an unknown date, the patient experienced muscle pain, erythema, swelling, pruritus and pain. On an unknown date, the outcome of the muscle pain, erythema, swelling, pruritus and pain were recovered/resolved and the outcome of the ringing in ears was not recovered/not resolved. It was unknown if the reporter considered the muscle pain, erythema, swelling, pruritus, pain and ringing in ears to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. Less than a year after vaccination, the patient experienced muscle pain, redness, swelling, itching and soreness. On 29th January 2019, the patient received 2nd dose of SHINGRIX. The reporter did not consent to follow up.
pt recv vax 16OCT95 & 28SEP96  2wk p/being exposed to pt w/chickenpox, pt devel chickenpox w/approx 25 pox over face & body & itching;1mo later pt had a scar on forehead from one pox that may have been infected;
Patient presented with generalized weakness, decreased appetite, nausea, and vomiting. Patient was diagnosed with Covid-19. Patient was in afib with RVR on arrival to ER since he was not able to take his medications for 3 days (unable to eat). Physical therapy recommended rehab. Patient was discharged to rehab.
This case was reported by a pharmacist via call center representative and described the occurrence of tinnitus aggravated in a male patient who received TWINRIX adult (batch number 797K7, expiry date 29th April 2017). Co-suspect products included TWINRIX adult. Concurrent medical conditions included tinnitus. On 1st July 2015, the patient received the 1st dose of TWINRIX adult. On an unknown date, the patient received the 2nd dose of TWINRIX adult. In August 2015, not applicable after receiving TWINRIX adult and an unknown time after receiving TWINRIX adult, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced tinnitus aggravated. On an unknown date, the outcome of the tinnitus aggravated and drug dose administration interval too long were unknown. It was unknown if the reporter considered the tinnitus aggravated to be related to TWINRIX adult. Additional details were provided as follows: The patient also received other vaccines on the same day but did not specify which vaccines. The patient was late for 2nd dose of TWINRIX adult and he was wondering how long he can wait for 2nd dose to receive, and still have it would be effective. The patient was also inquiring if there were any reports of tinnitus with TWINRIX. At the same time, the patient was emphasizing that he was not saying that TWINRIX caused tinnitus because he was already having tinnitus. The patient stated that, may be TWINRIX aggravated the tinnitus and may be not. The patient was extremely sensitive to offer any further information so no further information available. The reporter's call was transferred to MI.
Had all symptoms of COVID except Respiratory and loss of taste and smell.  Had 3 COVID tests which were all negative including the PBR test..  Low BP.  Was admitted to hospital
issues with uterus, my periods have been super heavy and then super light ever since the vaccine was administered; issues with uterus, my periods have been super heavy and then super light ever since the vaccine was administered; This is a spontaneous report from a contactable consumer or other non hcp.    A 17-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 16Mar2021 as dose 2, single for covid-19 immunisation. Medical history included neuropathy peripheral, food allergy, iodine allergy The patient's concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that, the patient experienced issues with uterus, my periods have been super heavy and then super light ever since the vaccine was administered on 16Mar2021 15:00 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 28May2021.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
I was never given a paper with information  Within 12 hrs I had a fever, muscle aches, headache, nausea,
Admitted on 7/4/21, H&P done by Dr. who noted: Diagnosis - pulmonary embolism History of Present Illness: got short of breath while cutting grass on Thursday. No history of stroke. Per his daughter he stopped taking all of his medications, including his dementia medicines. Family noticed more memory issues lately. D-dimer elevated, CT angio positive for P.E. in the left lower lung subsegmental artery branches, but no evidence of right heart strain, and lungs are clear. Heparin drip started. CBC and CMP showed no acute findings. BNP was 80, troponin less than 7. No family history of heart disease, heart attack, stroke, nor diabetes.
female patient was given an expired Daptacel injection/ no specific symptoms; Initial information received on 03-Jun-2019 regarding an unsolicited valid non-serious case received from other a non-health professional (office staff).  This case involves a 4 months 18 days old female patient who received vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and reported that female patient was given an expired Daptacel injection.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS B VACCINE (HEPATITIS B VACCINE).  On 31-May-2019, the patient received a dose of suspect 0.5 ml DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5171AA and expiry date: 23-Mar-2019 via intramuscular route in the left thigh.  It was a case of actual medication error due to expired product administered.  No specific symptoms were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
After having the vaccination,  had 104 fever the next day, achy, headache and didn't get out of bed. Next day felt better but not full of energy. Monday, thought felt better. The next day had really bad shoulder pain. Called doctor to let them know what was happening. Ask doctor was it normal, she said no. The PA , printed out information about the vaccine. Able to lift arm but still having some pain and headaches. Having trouble sleeping. It's been about 3 weeks.
Beginning approximately 10 hours after the vaccination: chills, headache, aches in hips & knees, nausea.  Woke up in the middle of the night because I was so cold even under the covers, and lying on either hip made it ache enough to wake me up.
Needle/syringe malfunctioned. Less than ½ dose administered in left deltoid. Per protocol, re-administered second dose in right deltoid.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 10 year old male with no pertinent medical history and allergy to AUGMENTIN who received subcutaneously into the right deltoid his first and second dose of VARIVAX (Merck) (lot # second dose 663327/0343Y) on 25-JUL-2001 and on 05-JUN-2009 respectively. There was no concomitant medication. The nurse reported that on 05-AUG-2010 the child came in for an office visit with what mom though was "bug bites". The patient was diagnosed with chicken pox and treatment was over the counter oral BENADRYL. On 09-AUG-2010 the child was seen for following follow-up and nurse stated that "the child was much better, he was recovering". Follow-up information has been received from a licensed practical nurse (L.P.N.) who indicated that the patient with unknown illness at time time of vaccination, on 09-AUG-2010 recovered from chicken pox. No relevant laboratory diagnostics studies were performed. No further information is available.
passed the recommended time frame for second dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) unknown route, Unknown dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (passed the recommended time frame for second dose) had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Arm swelling reaction, painful, itching, redness put compresses on, started with warm and alternated with cold and elevated it. Then 3 days later I started having bilateral leg stinging and burning from the knees to my ankles, that would last for 1-2 mins then again a couple of days later but didn't last as long. I haven't had it since. But now I have swelling and pain on both legs, they felt tight, started at the feet then turned to my  ankles and legs. They hurt to walk and the pain radiate to my hip. I rub my legs with a natural remedy and the next day it was fine. But a couple days later it started again and still today it is both feet hurt, sting, and swollen but have been elevating them.
Late that night of 1/8/04 pt awoke with itching, then next day bil hands swollen and tichy with hives and rash-progressing to swollen lips and tightness on throat. Mother call center and gave Benadryl and followed up next day (Sat.) with Dr.
Patient able to stick a magnet to injection sites of both arms which was given on 4/19/21 and 5/17/21.
Unspecified patients were inadvertently administered doses of VARIVAX and PROQUAD, on unspecified dates, that had been improperly stored.; No additional adverse event; This non-valid spontaneous report was received from a registered nurse concerning multiple unspecified patients. The patients' concurrent conditions, medical history and historical drug were not provided.  On an unknown dates, the patients were vaccinated for prophylaxis with the following inappropriately stored vaccines: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot # S030211 (therapy type rha), expiration date 25-MAR-2021; or varicella virus vaccine live (oka/merck) (VARIVAX) lot # S030227, expiration date 26-SEP-2021. Strengths, doses, and routes of administration were not provided. Both vaccines were reconstituted with a properly stored sterile diluent.  The temperatures involved were: -12.5 degrees Celsius in a time frame of 47 minutes. A previous temperature excursion was reported with a temperature involved of -14 degrees Celsius in a time frame of 23 minutes. A data logger was involved. No additional adverse events were reported.  This case was classified as non-valid since it does not have patient identifiers.  Follow-up information was received on 17-JUL-2020. As of 17-JUL-2020, all telephone attempts to obtain follow-up information have been unsuccessful.
At 11am, I developed constant dull right arm pain at injection site with erythema and swelling. Pain is 5/10, and much more painful than the arm pain that occurred for the first two days after the injection.  Took Advil which did not really help. Later in the evening also developed chills and general tiredness.
General body pain; body aches/ muscle aches and pains; headache; fatigue; chills; Fever; Vaccination site reaction; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Sep-2021 and was forwarded to Moderna on 08-Sep-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Sep-2021 and was forwarded to Moderna on 08-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE ("I am hurting all over"), MYALGIA (body aches/ muscle aches and pains), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE ("I am hurting all over"), MYALGIA (body aches/ muscle aches and pains), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (Fever). At the time of the report, MALAISE ("I am hurting all over"), MYALGIA (body aches/ muscle aches and pains), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (Fever) outcome was unknown.            No Concomitant drugs were reported.  No Treatment information  were reported. The patient reported "I have COVID arm. Delayed reaction".
Following influenza vaccine received yesterday, I had mild tenderness and redness for a few hours following. when I woke up this morning around 0600, I noticed moderate pain without touching, redness and swelling. My provider at the medical group measured the size of the induration at 7cm by 5cm with mild erythema.
bump is firm; pain in shoulder; has a pretty big bump at the site of injection; bump is red; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red). On 04-Mar-2021, ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, VACCINATION SITE INDURATION (bump is firm), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
No further AE.; Medical assistant calls to report RECOMBIVAX pediatric dose given to a 28 year old. 8/24/2023.  No further AE.  No PQC.; This spontaneous report has been received from a medical assistant, regarding a 28-years-old female patient. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided.  On 24-AUG-2023, the patient was vaccinated with a pediatric dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) intramuscular injection, as prophylaxis (lot number: W025817, which was determined to be valid as syringe formulation, with an expiration date on 21-AMY-2025) (strength, dose, route and anatomical location of administration were not reported) (Inappropriate dose of vaccine administered).   No additional adverse event was reported.
Chest tightness, tickly cough, red and burning eyes, congested ears 1 1/2 hrs after injection.
In March 2021 within about 5-10 days of 1st dose of Pfizer vaccine began to experience metallic/bad taste with food and beverages.  This is still ongoing and he has lost 35 pounds.  June 27th, 2021 experienced major heart attack with 100% blockage due to blood clot that originated in the heart.  July 14th, 2021 experienced a second major heart attack with 100% blockage due to blood clot that originated in the heart.
I got the Corona; That's a shock, I got the Corona; I got the Corona; That's a shock, I got the Corona; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID -19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first shot of COVID 19 vaccine and had to leave the country. Patient stated, "I got the Corona. That's a shock, I got the Corona and I am not going to be able to get out from here maybe for another 2 weeks because I have to be in currently in here. So, now what's going on with my first shot and what's going on my second, I have to make an appointment for my second shot or what else?" Patient added, "tomorrow I have the second shot, but I am not there, and I have the corona anyhow." Outcome of the event was unknown.  Information on lot/batch number has been requested.
Left arm is still sore primarily when I am lifting weights; This is a spontaneous report from a contactable consumer or other non hcp (Patient herself). A 51-years-old female (Non pregnant) patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection), via an unspecified route of administration, administered in Arm Left (Age at the time of vaccination 51-year-old) on 05Aug2021, at 17:30 as dose 1, single for covid-19 immunization. The patient did not receive other vaccine in four weeks. The patient medical history was not reported. Concomitant medications included in two weeks as vitamin d3 (VITAMIN D3), angelica sinensis, cimicifuga racemosa, hesperidin, oryzanol, vitex agnus-castus (MENOSENSE), turmeric [curcuma longa rhizome] (TURMERIC [CURCUMA LONGA RHIZOME]), diloxanide furoate, metronidazole (DIMET-PLUS) and ascorbic acid (VIT C). On 07Aug2021 at 09:45, in timeframe between vaccination and starting of symptoms was 2 days 9 hrs 45 min,  the patient experienced left arm is still sore primarily when she lifting weights. The patient underwent lab tests and procedures which included Binax (Nasal Swab) test was negative on 18Aug2021. The patient not had covid prior vaccination; tested for covid post vaccination. The patient did not receive any treatment for AE. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.